Clinical Trial Update: Real-Life Outcomes of Multiple Sclerosis Treatment With Rebif [NA]

View source ↗

Summary

This clinical trial update reports real-world outcomes for multiple sclerosis patients treated with Rebif (interferon beta-1a). The study is listed as completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Rebif (interferon beta-1a)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Multiple Sclerosis | NA | Status: COMPLETED